Integra LifeSciences eliminates COO role; Glenn Coleman to exit Oct 3, 2022

INTEGRA LIFESCIENCES HOLDINGS CORP

COO position eliminated effective October 3, 2022.
Glenn Coleman, current COO, will cease employment on that date.
Action is part of succession planning following the 2021 CEO transition.
No replacement named for the eliminated role.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Glenn Coleman

Chief Operating Officer

IART · INTEGRA LIFESCIENCES HOLDINGS CORP

Effective: 2022-10-03
Filed: August 29, 2022, 7:59 PM ET

Glenn Coleman, the Company’s current Chief Operating Officer, will cease employment with the Company on that date.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Glenn Coleman departed as Chief Operating Officer at INTEGRA LIFESCIENCES HOLDINGS CORP.

Action: cease employment
Role: Chief Operating Officer

Exact text from the filing

Glenn Coleman, the Company’s current Chief Operating Officer, will cease employment with the Company on that date.

View on SEC.gov

INTEGRA LIFESCIENCES HOLDINGS CORP filing history →

Source: SEC EDGAR

accession 0001193125-22-231825

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.